Related references
Note: Only part of the references are listed.Prognostic Value of Combined Detection of Serum IL6, YKL-40, and C-reactive Protein in Patients with Unresectable Pancreatic Cancer
Inna M. Chen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Prognostic impact of Charlson's Age-Comorbidity Index and other risk factors in patients with pancreatic cancer
Karin Bagni et al.
EUROPEAN JOURNAL OF CANCER CARE (2020)
The prognostic value of tumour-infiltrating lymphocytes in pancreatic cancer: a systematic review and meta-analysis
Adile Orhan et al.
EUROPEAN JOURNAL OF CANCER (2020)
Inflammation and Pancreatic Cancer: Focus on Metabolism, Cytokines, and Immunity
Andrea Padoan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The Tumor Microenvironment Innately Modulates Cancer Progression
Dominique C. Hinshaw et al.
CANCER RESEARCH (2019)
Cellular determinants and therapeutic implications of inflammation in pancreatic cancer
Meredith L. Stone et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Plasma/serum proteomics: depletion strategies for reducing high-abundance proteins for biomarker discovery
Pey Yee Lee et al.
BIOANALYSIS (2019)
Broadening the Impact of Immunotherapy to Pancreatic Cancer: Challenges and Opportunities
Vinod P. Balachandran et al.
GASTROENTEROLOGY (2019)
The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications
Xiaomeng Liu et al.
MOLECULAR CANCER (2019)
The effect of postoperative gemcitabine on overall survival in patients with resected pancreatic cancer: A nationwide population-based Danish register study
Louise Skau Rasmussen et al.
ACTA ONCOLOGICA (2019)
High throughput proteomics identifies a high-accuracy 11 plasma protein biomarker signature for ovarian cancer
Stefan Enroth et al.
COMMUNICATIONS BIOLOGY (2019)
IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer
Thomas A. Mace et al.
GUT (2018)
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Joshua D. Cohen et al.
SCIENCE (2018)
Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancer
Noomi Vainer et al.
Oncotarget (2018)
Serum Biomarker Signature-Based Liquid Biopsy for Diagnosis of Early-Stage Pancreatic Cancer
Linda D. Mellby et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Serum levels of IL-6, IL-8, and IL-10 are indicators of prognosis in pancreatic cancer
Lanyun Feng et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2018)
Imaging modalities in the diagnosis of pancreatic adenocarcinoma: A systematic review and meta- analysis of sensitivity, specificity and diagnostic accuracy
James Toft et al.
EUROPEAN JOURNAL OF RADIOLOGY (2017)
IL6 Receptor Blockade Enhances Chemotherapy Efficacy in Pancreatic Ductal Adenocarcinoma
Kristen B. Long et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
Joshua D. Cohen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Diagnostic performance enhancement of pancreatic cancer using proteomic multimarker panel
Jiyoung Park et al.
ONCOTARGET (2017)
Large-scale clinical validation of biomarkers for pancreatic cancer using a mass spectrometry-based proteomics approach
Jisook Park et al.
ONCOTARGET (2017)
Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases
Helen Ha et al.
THERANOSTICS (2017)
Advances in the Genetics and Biology of Pancreatic Cancer
Andrew J. Aguirre et al.
CANCER JOURNAL (2017)
Role of CCL20 mediated immune cell recruitment in NF-κB mediated TRAIL resistance of pancreatic cancer
Claudia Geismann et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2017)
Pancreatic cancer
Jorg Kleeff et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Cancer Cell-Autonomous TRAIL-R Signaling Promotes KRAS-Driven Cancer Progression, Invasion, and Metastasis
Silvia von Karstedt et al.
CANCER CELL (2015)
The role of CD95 and CD95 ligand in cancer
M. E. Peter et al.
CELL DEATH AND DIFFERENTIATION (2015)
Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis Or Diagnosis (TRIPOD): the TRIPOD statement
Gary S. Collins et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2015)
Serum CA19-9 Is Significantly Upregulated up to 2 Years before Diagnosis with Pancreatic Cancer: Implications for Early Disease Detection
Darragh P. O'Brien et al.
CLINICAL CANCER RESEARCH (2015)
Pancreatic Cancer, Inflammation, and Microbiome
Constantinos P. Zambirinis et al.
CANCER JOURNAL (2014)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
Role of the immune system in pancreatic cancer progression and immune modulating treatment strategies
K. Sideras et al.
CANCER TREATMENT REVIEWS (2014)
Pancreatic Adenocarcinoma
David P. Ryan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability
Erika Assarsson et al.
PLOS ONE (2014)
CA 19-9: handle with care
Claudio Galli et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2013)
Antitumoral activity of parvovirus-mediated IL-2 and MCP-3/CCL7 delivery into human pancreatic cancer: implication of leucocyte recruitment
Sebastian Dempe et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Stat3 and MMP7 Contribute to Pancreatic Ductal Adenocarcinoma Initiation and Progression
Akihisa Fukuda et al.
CANCER CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Evaluation of matrix metalloproteinase 7 in plasma and pancreatic juice as a biomarker for pancreatic cancer
Koert F. D. Kuhlmann et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
REporting recommendations for tumour MARKer prognostic studies (REMARK)
LM McShane et al.
BRITISH JOURNAL OF CANCER (2005)
Share Paper
